JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
JOHNSON & JOHNSON
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026
$253.79−1.77 (-0.69%)
Close on Oct 19, 2026
- Market cap
- $619.27B
- P/E (TTM)
- 29.4
- Dividend yield
- 2.03%
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
$5.14
+4.7% on the prior year
Consecutive increases
15 years
Every year since FY2010
Dividend yield
2.03%
Latest annual dividend ÷ share price
Payout ratio, FY2025
–
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | $5.14 | +4.7% | – | – |
| FY2024 | $4.91 | +4.5% | – | – |
| FY2023 | $4.70 | +5.6% | – | – |
| FY2022 | $4.45 | +6.2% | – | – |
| FY2021 | $4.19 | +5.3% | – | – |
| FY2020 | $3.98 | +6.1% | – | – |
| FY2019 | $3.75 | +5.9% | – | – |
| FY2018 | $3.54 | +6.6% | – | – |
| FY2017 | $3.32 | +5.4% | – | – |
| FY2016 | $3.15 | +6.8% | – | – |
| FY2015 | $2.95 | +6.9% | – | – |
| FY2014 | $2.76 | +6.6% | – | – |
| FY2013 | $2.59 | +7.9% | – | – |
| FY2012 | $2.40 | +6.7% | – | – |
| FY2011 | $2.25 | +6.6% | – | – |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.